Ropes & Gray advised TPG Capital and Clayton, Dubilier & Rice (CD&R) on regulatory matters and TPG Capital on governance in an agreement to acquire Covetrus, a global leader in animal health technology and services. TPG and CD&R will acquire all outstanding shares of Covetrus common stock not already owned by affiliates of CD&R for $21 per share in cash, representing an enterprise value of approximately $4 billion. The announcement was made on May 25 in a press release.
CD&R is a private investment firm that has managed the investment of more than $40 billion in over 100 companies with an aggregate transaction value of more than $175 billion since its inception. TPG Capital is the private equity platform of alternative asset management firm TPG, which manages $120 billion of assets under management and has investment and operational teams in 12 offices globally.
The Ropes & Gray team was led by private equity partners Chau Le and Jay Freedman, life sciences regulatory & compliance partner Gregory Levine and health care partner Michael Lampert, and included private equity counsel Peter Wang and litigation & enforcement partner Daniel McCaughey.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.